NRIX icon

Nurix Therapeutics

103 hedge funds and large institutions have $1.05B invested in Nurix Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

18% less capital invested

Capital invested by funds: $1.28B → $1.05B (-$237M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $13K

Holders
103
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$13K
Net Calls
Net Calls Change

Top Buyers

1 +$25.4M
2 +$15.2M
3 +$13.5M
4
State Street
State Street
Massachusetts
+$12.8M
5
Morgan Stanley
Morgan Stanley
New York
+$9.26M

Top Sellers

1 -$167M
2 -$28.8M
3 -$3.29M
4
Nomura Holdings
Nomura Holdings
Japan
-$2.68M
5
PCM
Pinz Capital Management
New York
-$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$107M
2
$90.8M
3
$84.6M
4
$65.1M
5
$55.4M
6
$52.2M
7
$49.3M
8
$38.9M
9
$37M
10
$34.1M
11
$32.5M
12
$32M
13
$31.8M
14
$31.7M
15
$24.4M
16
$18.2M
17
$18.2M
18
$18M
19
$17.5M
20
$15.2M
21
$13.5M
22
$12M
23
$11.8M
24
$11.3M
25
$10.5M